Advancements in Precision Oncology: Harnessing High-Throughput Screening and Computational Strategies for Targeted...

Area of Science:

• Oncology
• Pharmacotherapy
• Computational Biology

Background:

• Precision medicine revolutionizes cancer treatment with personalized therapies.
• Individualized treatments offer improved efficacy and reduced toxicity.
• High-throughput screening and computational methods are key to advancing oncology.

Purpose of the Study:

• To review the integration of high-throughput screening with computational methodologies (AI, machine learning) in oncology drug discovery.
• To explore the efficacy of various cancer therapeutics, including targeted therapies, CAR T-cell therapies, and immune checkpoint inhibitors.
• To evaluate the impact of in silico modeling on predicting drug efficacy, reducing costs, and improving time efficiency in drug development.

Main Methods:

• Review of scientific literature and data aggregation from key databases.
• Examination of high-throughput screening techniques.
• Analysis of computational methodologies, including artificial intelligence (AI) and machine learning, for in silico modeling.

Main Results:

• AI and machine learning expedite drug discovery and optimize treatment protocols in oncology.
• Combination therapies and biomarker identification refine patient-specific treatment strategies.
• In silico modeling demonstrates significant impact on drug efficacy predictions, cost reduction, and time efficiency.

Conclusions:

• Computational and synthetic approaches hold collaborative potential to redefine oncological pharmacotherapy.
• Integration of advanced methodologies enhances therapeutic efficacy and reduces toxicity in cancer treatment.
• Optimized drug discovery and treatment protocols lead to improved patient outcomes in oncology.